Safety of infliximab and adalimumab in pediatric inflammatory bowel diseases: a disproportionality analysis from the FAERS database
英夫利昔单抗和阿达木单抗在儿童炎症性肠病中的安全性:来自FAERS数据库的不均衡性分析
期刊:BMC Gastroenterology
影响因子:2.6
doi:10.1186/s12876-025-04154-w
Deng, Yanhong; Shi, Shengying; Feng, Senling; Tan, Xiangping; Wang, Yinling; Yin, Jinjin; Liu, Shaozhi; Gao, Yuanmei